dc.contributor.author | Powell, J | en_US |
dc.contributor.author | Shapiro, A | en_US |
dc.contributor.author | Ragni, M | en_US |
dc.contributor.author | Negrier, C | en_US |
dc.contributor.author | Windyga, J | en_US |
dc.contributor.author | Ozelo, M | en_US |
dc.contributor.author | Pasi, J | en_US |
dc.contributor.author | Baker, R | en_US |
dc.contributor.author | Potts, J | en_US |
dc.contributor.author | Li, S | en_US |
dc.contributor.author | Mei, B | en_US |
dc.contributor.author | Pierce, GF | en_US |
dc.contributor.author | Robinson, B | en_US |
dc.date.accessioned | 2015-02-24T10:53:01Z | |
dc.date.available | 2014-07-29 | en_US |
dc.date.issued | 2015-01 | en_US |
dc.identifier.issn | 0007-1048 | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/6729 | |
dc.format.extent | 113 - 123 | en_US |
dc.relation.ispartof | BRITISH JOURNAL OF HAEMATOLOGY | en_US |
dc.subject | administration and dosage | en_US |
dc.subject | factor IX | en_US |
dc.subject | haemophilia B | en_US |
dc.subject | pharmacokinetics | en_US |
dc.subject | recombinant fusion protein | en_US |
dc.title | Switching to recombinant factor IX Fc fusion protein prophylaxis results in fewer infusions, decreased factor IX consumption and lower bleeding rates | en_US |
dc.type | Article | |
dc.identifier.doi | 10.1111/bjh.13109 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000346151600014&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 1 | en_US |
pubs.notes | No embargo | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 168 | en_US |